Monoclonal antibodies (mAbs), thanks to their low toxicity and high specificity, have enjoyed incredible market success across a range of disease categories.

This eBook, sponsored by Evotec, examines the challenges, solutions and successes in mAb discovery and development.

Download this exclusive eBook to learn more about:

• The 2025 scientific breakthroughs in the field of mAbs
• How single-use technologies can improve antibody production
• Polyclonal and recombinant antibody development
• Overcoming the challenges of measuring antibody aggregation

Sponsored by: